Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma

Published:2016-01 Issue:1 Volume:27 Page:165-172
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Gupta M.,Stenson M.,O'Byrne M.,Maurer M.J.,Habermann T.,Cerhan J.R.,Weiner G.W.,Witzig T.E.

Funder

National Cancer Institute

National Institutes of Health

Predolin Foundation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/1/165/16701916/mdv486.pdf

Reference34 articles.

1. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes;Vose;J Clin Oncol,2008

2. Pathology of peripheral T-cell lymphomas: where do we stand?;Gaulard;Semin Hematol,2014

3. WHO classification of tumours of haematopoietic and lymphoid tissues;Swerdlow,2008

4. The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas;Briski;Blood Cancer J,2014

5. Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis;Yin;Acta Haematol,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy;New England Journal of Medicine;2024-09-05

2. Plasma IL-1 and IL-6 Family Cytokines with Soluble Receptor Levels at Diagnosis in Head and Neck Squamous Cell Carcinoma: High Levels Predict Decreased Five-Year Disease-Specific and Overall Survival;Cancers;2024-04-12

3. CXCL9 as a Reliable Biomarker for Discriminating Anti–IFN-γ-Autoantibody–Associated Lymphadenopathy that Mimics Lymphoma;Journal of Clinical Immunology;2023-12-28

4. Targeting the cGAS‐STING Pathway Inhibits Peripheral T‐cell Lymphoma Progression and Enhances the Chemotherapeutic Efficacy;Advanced Science;2023-12-25

5. Interleukin-1 receptor antagonist: An alternative therapy for cancer treatment;Life Sciences;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3